Home Medical Devices MRI Guided Neurosurgical Ablation Market Size & Risks by 2031

MRI Guided Neurosurgical Ablation Market

MRI Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report By Product (MRI-Guided Radiofrequency Ablation Systems, MRI-Guided Laser Ablation Systems, MRI-Guided Focused Ultrasound Systems, Accessories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD55618DR
Study Period 2019-2031 CAGR 6.54%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 161.29 Million
Forecast Year 2031 Forecast Year Market Size USD 285.26 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global MRI-guided neurosurgical ablation market size was valued at USD 161.29 million in 2022. It is estimated to reach USD 285.26 million by 2031, growing at a CAGR of 6.54% during the forecast period (2023–2031). The increasing prevalence of neurological disorders and advancements in MRI technology stimulate market growth.

MRI-guided neurosurgical ablation is used in minimally invasive procedures using a laser ablation device to treat various neuro-diseases, such as brain tumors. The technique may alleviate discomfort, hasten recovery, and reduce some surgical risks related to open brain tumor surgery. Additionally, MRI-guided laser ablation allows surgeons to treat glioblastoma, an aggressive glioma tumor that frequently relapses and can be fatal. Brain tumors, epilepsy, movement disorders (such as essential tremors or Parkinson's), and some psychiatric illnesses can all be treated by MRI-guided neurosurgical ablation. Compared to conventional neurosurgical procedures, it has the advantage of precision targeting and real-time monitoring, which can increase the procedure's safety and effectiveness.

Market Dynamics

Market Drivers

Increasing Prevalence of Neurological Disorders

The likelihood of neurological problems emerging is rising as the world's population ages. Numerous neurological disorders, including Parkinson's disease, Alzheimer's disease, and several forms of dementia, are more frequently found in older age groups. Healthcare personnel may now more accurately identify and diagnose neurological problems because of improvements in medical technology and diagnostic methods. This has raised reported prevalence rates by increasing awareness and improving detection rates. Given that several neurological illnesses have a genetic component, those with specific genetic predispositions may be more likely to experience these conditions.

Genetic and environmental variables influence the absolute risk of neurological illnesses. These elements working together have caused neurological problems to be more common worldwide. The expanding impact of neurological diseases on people, healthcare systems, and society emphasizes the need for effective prevention efforts, early detection, precise diagnosis, and breakthroughs in treatment choices.

Advancements in MRI Technology

Stronger magnetic fields, typically 3 Tesla or greater, have been developed for high-field MRI systems, which have increased picture quality, resolution, and signal-to-noise ratio. High-field MRI improves diagnostic accuracy by enabling greater visualization of minute anatomical details, tiny lesions, and subtle tissue changes. Real-time MRI techniques make it possible to acquire and view pictures in real-time, enabling dynamic imaging of moving objects, including the heart, joints, and digestive system. Applications for real-time MRI include monitoring joint movements, gauging cardiac function, and directing procedures and surgeries.

The creation of MRI-compatible medical devices, such as surgical instruments, implants, and prostheses, has been made easier by advancements in MRI technology. Better patient management and treatment planning are made possible using these gadgets, specially made to be secure in the MRI setting. In general, improvements in MRI technology have increased the technique's clinical relevance and enhanced its diagnostic capacities across various medical disciplines. These developments have improved patient care in neurology, cancer, cardiology, orthopedics, and numerous other medical specialties by enabling more precise and accurate diagnoses, better treatment planning, and more thorough patient care.

Market Restraint

Competition from Alternative Treatments and Lack of Awareness

Other therapeutic techniques for neurological illnesses, such as conventional open surgery, radiation therapy, or pharmacological therapies, compete with MRI-guided neurosurgical ablation. MRI-guided ablation procedures may be affected by various factors, including patient-specific characteristics, disease stage, and clinician preferences. A significant barrier might be a lack of knowledge regarding the benefits and availability of MRI-guided neurosurgical ablation among patients, referring doctors, and healthcare professionals. Additionally, because of the specialist nature of these treatments, neurosurgeons and interventional radiologists must get training and competence, which could present problems in developing skills and sharing knowledge.

Market Opportunities

Expansion of Indications

There is potential for extending the indications for MRI-guided neurosurgical ablation beyond the existing management of neurological disorders. Ablation techniques may be used to treat diseases like epilepsy, mobility problems, chronic pain, and psychiatric illnesses, according to ongoing research and clinical studies. This could result in new therapeutic choices and expanded market potential.

Regional Analysis

Based on region, the global MRI-guided neurosurgical ablation market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America is the most significant global MRI-guided neurosurgical ablation market shareholder over the forecast period. In 2022, the North American regional market for MRI-guided neurosurgical ablation systems was anticipated to hold 47.3% of the global market share. The expansion of the market in North America is being driven by an increase in the prevalence of certain ailments, such as neurodegenerative illnesses and brain tumors, the majority of which are malignant. The region's market is anticipated to increase due to rising demand for MRI-guided laser ablation for brain tumors, rising MRI-guided laser interstitial thermal treatment (LITT), and the presence of well-established healthcare institutions. The market's demand for MRI-guided neurosurgical ablation and associated equipment is anticipated to increase as people become more aware of the benefits of minimally invasive surgery.

Europe is anticipated to grow steadily over the forecast period. Countries with advanced healthcare systems and considerable emphasis on technology breakthroughs include Germany, the United Kingdom, and France. Additionally, the region's favorable reimbursement policies and rising demand for minimally invasive treatments propel market expansion.

Asia-Pacific has emerged as one of the fastest-growing regions in the global market. Infrastructure investments in healthcare have been made by nations like China, Japan, India, and South Korea, who have also embraced cutting-edge medical technologies. Growing patient numbers, greater knowledge of minimally invasive procedures, and rising healthcare costs all support market expansion in this area.

Additionally, the introduction of technologically enhanced items into the market has been prompted by an increase in neurological illnesses, particularly brain tumors, in industrialized and developing nations. For instance, tremor-dominant Parkinson's disease (PD) and essential tremors are treated with Insightec's MR-guided Focused Ultrasound (MRgFUS). The targeted brain tissue is heated and removed during this technique without making any incisions. As a result, industry players are constantly working to provide technologically sophisticated products to the marketplace.

In LAMEA, opportunities for market expansion are created by the expanding healthcare infrastructure, rising healthcare costs, and rising prevalence of neurological illnesses. The MRI-guided neurosurgical ablation market is anticipated to expand steadily in the Middle East and Africa. The market is growing due to better healthcare infrastructure, rising healthcare facility investments, and a growing emphasis on implementing cutting-edge medical technologies. In contrast to other regions, the market in this one is comparatively smaller.

Report Scope

Report Metric Details
Segmentations
By Product
  1. MRI-Guided Radiofrequency Ablation Systems
  2. MRI-Guided Laser Ablation Systems
  3. MRI-Guided Focused Ultrasound Systems
  4. Accessories
Company Profiles Medtronic INSIGHTEC Boston Scientific Corporation Monteris Medical Inc. MRI Interventions Inc. AngioDynamics Inc. ClearPoint Neuro Inc. Smith & Nephew plc St. Jude Medical Inc.
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global MRI-guided neurosurgical ablation market is bifurcated into products.

Based on the product, the global MRI-guided neurosurgical ablation market is bifurcated into MRI-guided radiofrequency, laser ablation systems, MRI-guided focused ultrasound systems, and accessories.

The accessories segment dominates the global market and is projected to exhibit a CAGR of 7.3% over the forecast period. Curettes, dissectors, clamps, spatulas, and rongeurs are accessories used during surgery. This section also offers numerous spare parts and add-ons for focused ultrasound, RF ablation, and laser procedures. Muscles or other tissues can be sliced, scraped, or rasped from the bone using neurosurgical curettes. They come with different cup sizes, angled heads, and shaft options. In minimally invasive discectomy treatments, tissues are divided using neurosurgical dissectors. Either one or both ends are single or double-ended. These tools are made to assist neurosurgeons with the diagnosis, avoidance, therapy, and surgical correction of problems that affect particular parts of the neurological system. These attachments' functionality, maneuverability, and precision help assure a patient's safety during surgical procedures. Some reasons fueling the market growth include introducing technologically enhanced goods by key players and increasing minimally invasive operations.

Market Size By Product

Market Size By Product
  • MRI-Guided Radiofrequency Ablation Systems
  • MRI-Guided Laser Ablation Systems
  • MRI-Guided Focused Ultrasound Systems
  • Accessories
  • Recent Developments

    Top Key Players

    MRI Guided Neurosurgical Ablation Market Share of Key Players

    MRI Guided Neurosurgical Ablation Market Share of Key Players
    Medtronic INSIGHTEC Boston Scientific Corporation Monteris Medical Inc. MRI Interventions Inc. AngioDynamics Inc. ClearPoint Neuro Inc. Smith & Nephew plc St. Jude Medical Inc. Others

    Frequently Asked Questions (FAQs)

    What is the estimated growth rate (CAGR) of the Market?
    The global MRI-guided neurosurgical ablation market is expected to grow at a CAGR of 6.54% during the forecast period 2023-2031.
    Top key players in the market include Medtronic, INSIGHTEC, Boston Scientific Corporation, Monteris Medical Inc., MRI Interventions Inc., AngioDynamics Inc., ClearPoint Neuro Inc., Smith & Nephew plc, and St. Jude Medical Inc.
    North America is the dominant region in the global MRI-guided neurosurgical ablation market, holding 47.3% of the market share in 2022.
    The increasing prevalence of neurological disorders and advancements in MRI technology are major drivers for market growth.
    The market is segmented by product into MRI-guided radiofrequency ablation systems, MRI-guided laser ablation systems, MRI-guided focused ultrasound systems, and accessories.
    Competition from alternative treatments and lack of awareness pose significant risks to the market.


    We are featured on :